Gregory I. Berk M.d.

Biography

 Dr. Gregory I. Berk, also known as Greg, M.D. has been Senior Advisor at Verastem, Inc since January 19, 2017. Dr. Berk served as Chief Medical Officer at Verastem, Inc since April 15, 2016 until January 19, 2017. Dr. Berk served as President and Chief Medical Officer at Sideris Pharmaceuticals, Inc. since January 7, 2014 until December 2015. Dr. Berk served as Chief Medical Officer of BIND Therapeutics, Inc from December 2012 to January 14, 2014, where he led the clinical development of its oncology focused programs, including Phase 2 programs for both non-small cell lung cancer and metastatic castrate-resistant prostate cancer. Dr. Berk was responsible for leading the global clinical development strategy and clinical operations at BIND Therapeutics, Inc. He was employed at SuperGen. He served as Chief Medical Officer of Intellikine LLC since July 12, 2011. Dr. Berk served as Senior Vice President of Global Clinical Development at Celgene Corporation, where he was a key member of the Celgene-Abraxis Integration team during Celgene's acquisition of Abraxis BioScience. Prior to Celgene, Dr. Berk served as Senior Vice President of Global Clinical Development at Abraxis BioScience, where he was responsible for overall clinical strategy, including efforts to expand the indications for Abraxane in lung cancer, pancreatic cancer and malignant melanoma. During this time, Dr. Berk served as an investigator on several industry-sponsored and cooperative group clinical trials, including the pivotal trials for Gleevec(R) and Avastin(R). Dr. Berk has been Member of Clinical and Scientific Advisory Board at Verastem, Inc since January 19, 2017. Dr. Berk obtained his medical degree from Case Western Reserve University and completed his internship, residency and fellowship in internal medicine, hematology and medical oncology, at the Weill Medical College of Cornell University and New York Presbyterian Hospital, where he also served as a faculty member from 1989 to 2004.

Research Interest

 clinical equipment,bioscience